Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency
- 2 June 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 104 (8), 2071-2079
- https://doi.org/10.1038/ajg.2009.231
Abstract
Atrophic body gastritis (ABG) is an autoimmune condition eventually manifesting itself as pernicious anemia (PA). Parietal cell autoantibodies (PCAs) and intrinsic factor autoantibodies (IFAs) are considered characteristics of these conditions. Recent studies on IFA and PCA frequency with respect to cobalamin deficiency in biopsy-proven ABG patients are lacking. We addressed this issue using new enzyme-linked immunosorbent assay (ELISA)-based assays. Sera from 165 patients with histologically diagnosed ABG and 113 controls were tested for IFA and PCA using ELISA. A total of 81 ABG patients had cobalamin deficiency and macrocytic anemia (Group 1-PA), 36 had cobalamin deficiency without macrocytic anemia (Group 2), and 48 had normal cobalamin levels (Group 3). IFAs were detected in 44/165 ABG patients (27% sensitivity) and in 0/113 controls (100% specificity). PCAs were detected in 134 ABG patients (81% sensitivity) and in 11 controls (90% specificity). In Group 1, IFAs showed 37% sensitivity and 100% specificity, whereas PCAs showed 81% sensitivity and 90% specificity. Combining IFA and PCA testing increased the sensitivity to 61% in all ABG patients and to 73% in Group 1, while maintaining 100% specificity. IFAs are 100% specific for biopsy-proven ABG and occurred in 27% of patients. PCAs occurred in 81% of ABG patients and in 10% of controls. Combining IFA and PCA testing significantly increases their diagnostic performance for ABG and PA, yielding a 73% sensitivity for PA. The non-invasive combined PCA and IFA assessment may be useful in selecting patients at risk for autoimmune gastritis to be confi rmed by gastroscopic–histologic examination.This publication has 25 references indexed in Scilit:
- Occurrence and Risk Factors for Autoimmune Thyroid Disease in Patients with Atrophic Body GastritisThe American Journal of Medicine, 2008
- Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented ReviewJournal of Clinical Endocrinology & Metabolism, 2008
- Autoimmune Gastritis: Historical Antecedents, Outstanding Discoveries, and Unresolved ProblemsInternational Reviews of Immunology, 2005
- Pernicious AnaemiaAutoimmunity, 2004
- Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen IEuropean Journal of Gastroenterology & Hepatology, 2003
- Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes.Diabetes Care, 2000
- High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia A prospective screening studyThe American Journal of Gastroenterology, 1999
- Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United StatesClinical Immunology and Immunopathology, 1997
- Prevalence of undiagnosed pernicious anemia in the elderlyArchives of Internal Medicine, 1996
- Serum Pepsinogen I and Serum Gastrin in the Screening of Severe Atrophic Corpus GastritisScandinavian Journal of Gastroenterology, 1991